|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent KNTE insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why KNTE insider buys are important for investors to follow.
Date | Insider | Price | Amount |
5-8-2023 Insider Buy |
Foresite Capital Management IV, LLC >10% Owner |
$2.80
CAGR »
|
$4,984,000.00 1,780,000 shares |
5-8-2023 Insider Buy |
James B. Tananbaum Director and >10% Owner |
$2.80
CAGR »
|
$4,984,000.00 1,780,000 shares |
5-5-2023 Insider Buy |
ORBIMED ADVISORS LLC Director and >10% Owner |
$2.80
CAGR »
|
$4,086,234.61 1,460,932 shares |
5-5-2023 Insider Buy |
Carl L. Gordon Director and >10% Owner |
$2.80
CAGR »
|
$4,086,234.61 1,460,932 shares |
5-2-2023 Insider Buy |
Carl L. Gordon Director and >10% Owner |
$2.61
CAGR »
|
$3,673,900.83 1,405,168 shares |
5-2-2023 Insider Buy |
ORBIMED ADVISORS LLC Director and >10% Owner |
$2.61
CAGR »
|
$3,673,900.83 1,405,168 shares |
3-14-2022 Insider Buy |
Richard Thomas Williams Chief Medical Officer |
$8.47
CAGR »
|
$338,850.00 40,000 shares |
2-15-2022 Insider Buy |
Carl L. Gordon Director |
$10.17
CAGR »
|
$1,989,446.00 195,700 shares |
2-15-2022 Insider Buy |
ORBIMED ADVISORS LLC Director |
$10.17
CAGR »
|
$1,989,446.00 195,700 shares |
12-3-2020 Insider Buy |
James B. Tananbaum
|
$20.00
CAGR »
|
$20,000,000.00 1,000,000 shares |
12-2-2020 Insider Buy |
ORBIMED ADVISORS LLC
|
$20.00
CAGR »
|
$15,000,000.00 750,000 shares |
12-2-2020 Insider Buy |
Carl L. Gordon
|
$20.00
CAGR »
|
$15,000,000.00 750,000 shares |
Also See: Institutional Holders of KNTE
Also See: SEC filings
Below we present the annualized performance delivered by KNTE stock since 5-8-2023 (the date of the most recent
insider purchase). The performance of the investment from the time KNTE insider buying occurred is the ultimate
test of whether insiders were right about KNTE being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
05/09/2023 |
|
End date: |
04/03/2024 |
|
Start price/share: |
$3.34 |
|
End price/share: |
$2.65 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-20.66% |
|
Annualized Gain: |
-22.85% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$7,934.00 |
|
Years: |
0.90 |
|
KNTE Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent KNTE insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding KNTE
|
|